Clinical Trial Update: Raloxifene in Preventing Breast Cancer in Premenopausal Women [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating raloxifene for the prevention of breast cancer in premenopausal women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Raloxifene (raloxifene)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED